Fundraising Fox

JUMPCODE Genomics

San Diego, US · Founded 2016 · Delaware corporation · 2 known investors

jumpcodegenomics.com ↗

Jumpcode Genomics develops programmable endonuclease enzymes for next-generation sequencing and PCR applications. The company's technology enables researchers to remove uninformative sequences and improve data quality for genomics applications including single-cell analysis, microbiome characterization, and infectious disease detection.

BiotechDeep Techin /jumpcodegenomics@JumpcodeG

Founders & leadership

DM
David Michael SalterExecutive Officer, Director
EC
Eugene ChenDirector
KB
Keith BrownExecutive Officer, Director
JR
Joel RotroffDirector
CT
Court TurnerDirector
JL
Joseph LeeDirector
KM
Kirk MalloyDirector

Investors · 2

Arboretum VenturesAnn Arbor · $5M – $15M
LYZZ CapitalShanghai

Reported raises · per SEC filings

Form D private placements
▶$3.5MraisedAug 2024 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Michael SalterExecutive Officer, Director
  • Court TurnerDirector
  • Joseph LeeDirector
Offering amount
$11.5M
Amount sold
$3.5M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.2MraisedMay 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yaron HakakExecutive Officer, Director
  • Frank WitneyDirector
  • Court TurnerDirector
  • Kirk MalloyDirector
  • Dan KidleDirector
  • Brandon PoeExecutive Officer
Offering amount
$16.1M
Amount sold
$9.2M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedDec 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith BrownExecutive Officer
  • Yaron HakakExecutive Officer, Director
  • Dan KidleDirector
  • Kirk MalloyDirector
  • Kevin LiDirector
  • Frank WitneyDirector
  • Michael LiangDirector
Offering amount
$21M
Amount sold
$21M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith BrownExecutive Officer, Director
  • Eugene ChenDirector
  • Kevin LiDirector
  • Joel RotroffDirector
  • Kirk MalloyDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2018 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene ChenDirector
  • Keith BrownExecutive Officer, Director
  • Joel RotroffDirector
  • Kirk MalloyDirector
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.